Home / Markets / Capital Market News / Glenmark USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Glenmark USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Last Updated : Dec 23 2025 | 2:55 PM IST

Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial. Glenmark's Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial is bioequivalent and therapeutically equivalent to the reference listed drug, Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) of BPI Labs, LLC, NDA 205029.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

Stock Alert: HCL Tech, Sanghvi Movers, Prestige Estate Projects, Saatvik Green Energy

Domestic banking system liquidity remained largely in surplus, says RBI

India, New Zealand Conclude FTA Talks to Boost Trade, Investments and Export Diversification

High-frequency indicators for November point to robust industrial activity

India's financial stability parameters remained robust, says RBI Governor

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 23 2025 | 9:17 AM IST